EcoDrugPlus

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSELUG00000002581
Gene Symbol: DPYD
1 Cross references
214 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSELUG00000004650
Gene Symbol: DDR2
3 Cross references
190 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSELUG00000003697
Gene Symbol: DDR2
3 Cross references
205 Possible Orthologues:

Disintegrin And Metalloproteinase Domain-Containing Protein 17

Ensembl ID : ENSELUG00000012677
Gene Symbol: LOC105016077
3 Cross references
209 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSELUG00000022986
Gene Symbol: DRD1
3 Cross references
201 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSELUG00000005222
Gene Symbol: DRD1
4 Cross references
189 Possible Orthologues:

Dopamine Receptor D2a

Ensembl ID : ENSELUG00000015578
Gene Symbol: DRD2A
1 Cross references
207 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSELUG00000013460
Gene Symbol: DRD3
3 Cross references
203 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSELUG00000011012
Gene Symbol: DRD5
1 Cross references
148 Possible Orthologues:

Dual Specificity Mitogen-Activated Protein Kinase Kinase 2

Ensembl ID : ENSELUG00000018291
Gene Symbol: LOC105011557
3 Cross references
218 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSELUG00000018089
Gene Symbol: ENPP2
3 Cross references
226 Possible Orthologues:

Egl Nine Homolog 1

Ensembl ID : ENSELUG00000013701
Gene Symbol: LOC105012182
2 Cross references
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).